These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22348324)
1. Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer. Wu X; Zhang X; Zhang H; Su P; Li W; Li L; Wang Y; Liu W; Gao P; Zhou G Cancer Sci; 2012 May; 103(5):959-67. PubMed ID: 22348324 [TBL] [Abstract][Full Text] [Related]
2. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer. Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091 [TBL] [Abstract][Full Text] [Related]
3. Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells. Wu X; Zhang X; Sun L; Zhang H; Li L; Wang X; Li W; Su P; Hu J; Gao P; Zhou G Cell Physiol Biochem; 2013; 32(2):344-54. PubMed ID: 23988382 [TBL] [Abstract][Full Text] [Related]
4. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells]. Zhang YH; Li G; Yu J; Xu MS; Liu ZX Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells. Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells. Zhang Y; Zhou G; Wang H; Zhang X; Wei F; Cai Y; Yin D Oncology; 2006; 71(5-6):446-55. PubMed ID: 17878748 [TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells. Wang H; Lee EW; Zhou L; Leung PC; Ross DD; Unadkat JD; Mao Q Mol Pharmacol; 2008 Mar; 73(3):845-54. PubMed ID: 18042733 [TBL] [Abstract][Full Text] [Related]
8. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Wang H; Zhou L; Gupta A; Vethanayagam RR; Zhang Y; Unadkat JD; Mao Q Am J Physiol Endocrinol Metab; 2006 May; 290(5):E798-807. PubMed ID: 16352672 [TBL] [Abstract][Full Text] [Related]
9. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Imai Y; Ishikawa E; Asada S; Sugimoto Y Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404 [TBL] [Abstract][Full Text] [Related]
10. [Transcriptional regulation of breast cancer resistance protein]. Wu XG; Peng SB; Huang Q Yi Chuan; 2012 Dec; 34(12):1529-36. PubMed ID: 23262099 [TBL] [Abstract][Full Text] [Related]
11. Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells. Selever J; Gu G; Lewis MT; Beyer A; Herynk MH; Covington KR; Tsimelzon A; Dontu G; Provost P; Di Pietro A; Boumendjel A; Albain K; Miele L; Weiss H; Barone I; Ando S; Fuqua SA Clin Cancer Res; 2011 Oct; 17(20):6510-21. PubMed ID: 21878538 [TBL] [Abstract][Full Text] [Related]
12. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Ee PL; Kamalakaran S; Tonetti D; He X; Ross DD; Beck WT Cancer Res; 2004 Feb; 64(4):1247-51. PubMed ID: 14973083 [TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein. Chen WJ; Wang H; Tang Y; Liu CL; Li HL; Li WT Chin J Cancer; 2010 Feb; 29(2):151-7. PubMed ID: 20109342 [TBL] [Abstract][Full Text] [Related]
14. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells. Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170 [TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Doyle L; Ross DD Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842 [TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter. De Amicis F; Zupo S; Panno ML; Malivindi R; Giordano F; Barone I; Mauro L; Fuqua SA; Andò S Mol Endocrinol; 2009 Apr; 23(4):454-65. PubMed ID: 19147702 [TBL] [Abstract][Full Text] [Related]
17. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells. Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818 [TBL] [Abstract][Full Text] [Related]
18. Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell lines. Elahian F; Kalalinia F; Behravan J Oncol Res; 2009; 18(1):9-15. PubMed ID: 19911699 [TBL] [Abstract][Full Text] [Related]
19. Progesterone acts via progesterone receptors A and B to regulate breast cancer resistance protein expression. Vore M; Leggas M Mol Pharmacol; 2008 Mar; 73(3):613-5. PubMed ID: 18086804 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Nakanishi T; Ross DD Chin J Cancer; 2012 Feb; 31(2):73-99. PubMed ID: 22098950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]